The Marcus (MCS) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
9 Nov, 2026Executive summary
FY2023 results improved as a diverse film slate supported theatre growth, while healthy leisure travel and stronger group events aided hotel performance.
FY2023 revenue rose 7.7% to $729.6M; operating income increased to $33.9M from $8.3M, and net earnings were $14.8M versus a $12.0M net loss.
Financial highlights
Q4 FY2023 revenue was $161.5M, down 0.9% YoY; operating income was $1.2M versus a $2.7M loss, and net loss narrowed to $1.4M from $9.3M.
Q4 diluted loss per share was $0.05 versus $0.30; Adjusted EBITDA increased 10.1% to $18.2M.
FY2023 diluted EPS was $0.46 versus a $0.39 loss; Adjusted EBITDA rose 27.8% to $108.7M.
Outlook and guidance
Fiscal 2024 film quantity is expected to be lower due to production delays from WGA and SAG-AFTRA strikes; multiple releases are contributing to early FY2024 results, with further schedule changes possible.
FY2024 group booking pace is ahead of comparable prior-year pace even excluding the Republican National Convention; FY2025 group pace and FY2024–25 banquet and catering pace are also ahead YoY.
Renovations at The Pfister Hotel and Grand Geneva Resort & Spa are nearing completion; Grand Geneva meeting and event space work is expected to finish in spring 2024.
Latest events from The Marcus
- FY22 recovery lifted EBITDA, but film supply and business travel remain constraints.MCS
Q4 2022 - Recovery lifted FY2021 Adjusted EBITDA to $35.1M, but the net loss remained $43.3M.MCS
Q4 2021 - Pandemic closures drove a $124.8M loss, with recovery hinging on reopening and demand.MCS
Q4 2020 - Record revenue, lower earnings, and COVID-19 closures reshaped the outlook.MCS
Q4 2019 - Record revenue and operating income; Movie Tavern expands the footprint as FY2019 investment rises.MCS
Q4 2018 - Record earnings and theatre outperformance powered growth amid acquisition-led expansion.MCS
Q4 2016 - Record FY2017 results, boosted by theatre growth and a one-time tax benefit.MCS
Q4 2017 - Record revenue and segment growth; adjusted earnings rose nearly 12%.MCS
Q4 2015 - F2014 earnings rose on stronger theatres and hotels, with elevated investment and market risks ahead.MCS
Q4 2014